[Longitudinal study of the metabolic syndrome after kidney transplantation]

Rafael Fernández Castillo1, Ruth Fernández Gallegos2, Gloria María Zaragoza Fernández3

  • 1Universidad de Granada. Facultad de Ciencias de la Salud. Departamento de Enfermería.. rafaelfernandez@ugr.es.

Abstract

Insights

Metabolic syndrome (MS) affects nearly 40% of kidney transplant patients, increasing graft failure risk. Strict monitoring of factors like BMI, hypertension, and diabetes is crucial for better outcomes.

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Metabolic Disorders

Background:

  • Metabolic syndrome (MS) is a significant post-transplant complication.
  • MS is linked to increased graft failure, obesity, and new-onset diabetes.
  • Understanding MS prevalence and risk factors in renal transplant recipients is critical.

Purpose of the Study:

  • To determine the prevalence of MS in renal transplant patients.
  • To identify risk factors associated with MS development.
  • To evaluate the association between MS and allograft dysfunction.

Main Methods:

  • Study included 138 renal transplant patients (83 male, 55 female) followed for over five years.
  • Analyzed risk factors: BMI, weight, hypertension, diabetes, lipids (LDL, HDL, triglycerides), and immunosuppressants.
  • Assessed acute rejection episodes and renal function (glomerular filtration rate).

Main Results:

  • The prevalence of MS was 39.85%.
  • Significant risk factors included BMI, overweight, HDL, triglycerides, LDL, hypertension, and diabetes.
  • High rates of acute rejection and impaired glomerular filtration rate were observed.

Conclusions:

  • High MS prevalence significantly compromises renal function and graft survival.
  • Strict control and monitoring of identified risk factors are essential.
  • Early intervention can mitigate MS impact on transplant outcomes.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
768
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
865
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
599
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.2K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
518